Navigation Links
Reportlinker Adds Molecular Diagnostics Market: DNA Probes and Biochips -- New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers
Date:6/21/2010

NEW YORK, June 21 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Molecular Diagnostics Market: DNA Probes and Biochips -- New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers

http://www.reportlinker.com/p0207178/Molecular-Diagnostics-Market-DNA-Probes-and-Biochips----New-Product-Development-Opportunities-and-Business-Expansion-Strategies-for-Instrument-and-Reagent-Suppliers.html

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next ten years will witness significant developments in reagent systems and automation, as well as the introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems which will utilize amplification methods.

In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new DNA probe and biochip technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostics companies during the next ten years.

This comprehensive worldwide study is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities emerging in the molecular diagnostics market during the next decade. The study explores business and technological trends in major markets; provides 5-and 10-year test volume and sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next ten years.

Contains 1,050 pages and 96 tables

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch. 

WORLDWIDE MARKET OVERVIEW, 2008-2017

The study will provide a concise strategic overview of the worldwide electronics market, including five-year forecasts for major geographic regions, market segments and product categories.

In addition, a review of the major U.S. and international economic, technological, demographic, social and regulatory trends with potentially significant impact on the electronics market during the next five years will be presented.

COMPANY STRATEGIC ASSESSMENTS

The following companies have been selected as the TOP 10 suppliers with the highest worldwide sales of electronic products: For each of the Top 10 companies, the report will provide an approximately 65-page strategic analysis, including the following information:

SECTION I: EXECUTIVE SUMMARY

A 3-5 page synopsis of key sections.

SECTION II: BUSINESS ORGANIZATION

History of the company's electronics business evolution, important to the understanding of the corporate culture, management mentality and strategies.

Most recent acquisitions, divestitures and significant organizational changes.

Current organizational structure.

SECTION III: SENIOR MANAGEMENT

Background of senior managers.

SECTION IV: FACILITIES AND EMPLOYEES

Major administrative, manufacturing and R&D facilities in the U.S. and abroad.

Manufacturing practices.

New plants under construction.

U.S. and international work force.

SECTION V: TECHNOLOGICAL KNOW-HOW

Internally developed and acquired technologies, processes and related capabilities.

Proprietary know-how and patent litigations.

SECTION VI: PRODUCT PORTFOLIO ANALYSIS

Review of major product lines.

Most recent new product introductions and line extensions.

SECTION VII: MARKETING TACTICS

Sales force in the U.S. and international markets.

Distribution strategies.

Promotional tactics.

SECTION VIII: FINANCIAL ANALYSIS

The U.S. and international sales and operating profit estimates by division, geographic region, market segment and product line.

Five-year sales and operating profit performance.

SECTION IX: R&D EXPENDITURES AND MAJOR PROGRAMS

Estimated R&D budget.

Research facilities and staff.

New technologies, products and product line extensions in development.

SECTION X: COLLABORATIVE ARRANGEMENTS

Major joint venture, product development and marketing partners.

Terms of collaborative agreements and specific products involved.

SECTION XI: STRATEGIC DIRECTION

Strengths and weaknesses.

Specific business, new product development and marketing objectives and strategies.

Anticipated acquisitions, joint ventures and divestitures.

COMPARATIVE ANALYSIS

In this section of the report, the Top 10 companies will be ranked according to the following criteria:

Worldwide sales of electronic products.

Sales estimated in North America, Europe, Japan and other regions.

Sales estimates by major product category.

Operating profit, and margins.

R&D expenditures, and others.

To order this report:

Blood Supply, Tissue Banking and Transplantation Industry: Molecular Diagnostics Market: DNA Probes and Biochips -- New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies
2. Reportlinker Adds Biomarkers - Technologies, Markets and Companies
3. Reportlinker Adds Future of Red Biotechnology in China
4. Reportlinker Adds The Future of Nutrigenomics: New opportunities in personalized nutrition and food-pharma collaboration
5. Reportlinker Adds the Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles)
6. Reportlinker Adds SNP Genotyping and Analysis Markets
7. Reportlinker Adds Infectious Disease Molecular Diagnostic Testing
8. Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement
9. Reportlinker Adds Biotechnology Instrumentation - International Market Trends
10. Reportlinker Adds Microplate Instrumentation & Supplies - A Global Market Perspective
11. Reportlinker Adds Pharmacodynamic Assays
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... ... February 21, 2017 , ... During ... connected digital health applications, announced a partnership with Redox, a leader in cloud-based ... to many clinical systems while keeping data secure in the cloud. , The ...
(Date:2/21/2017)... ... 2017 , ... The medical potential of stem cells is both extensive and ... due to their differentiating characteristics. Stem cells are unique as the have the potential ... to become tissue or organic-specific cells with special functions. , Stem cell therapy ...
(Date:2/21/2017)... and VANCOUVER, British Columbia , Feb. ... ) today announced that apatorsen results from two randomized Phase ... Clinical Oncology (ASCO) 2017 Genitourinary Cancers Symposium, held February 16 ... . Clinical data from trials in bladder and prostate cancers ... in combination with standard-of-care treatments. ...
(Date:2/21/2017)... , Feb. 21, 2017   Invitae Corporation ... information companies, today announced that members of the company,s ... 37th Annual Health Care Conference on Monday, March 6, ... Pacific in Boston, Massachusetts . ... may be accessed by visiting the investors section of ...
Breaking Biology Technology:
(Date:2/7/2017)... 7, 2017   MedNet Solutions , an innovative ... of clinical research, is pleased to announce that the ... innovative, highly flexible and award winning eClinical solution, is ... iMedNet is a proven Software-as-a-Service (SaaS) clinical research ... (EDC), but also delivers an entire suite of eClinical ...
(Date:2/7/2017)... 7, 2017 Ipsidy Inc. ( ... [OTC: IDGS], ("Ipsidy" or the "Company") a provider of ... services, is pleased to announce the following changes as ... Effective January 31, 2017, Philip D. Beck ... and President.  An experienced payment industry professional and public ...
(Date:2/3/2017)... -- Texas Biomedical Research Institute announced that its Board of Trustees ... the Institute,s new President and CEO. Dr. Schlesinger will take ... is currently the Chair of the Department of Microbial Infection ... Biology at Ohio State University. "We are delighted ... of Texas Biomed," said Dr. James O. Rubin , ...
Breaking Biology News(10 mins):